Tuesday, June 25, 2019

Neglected Tropical Diseases Drugs and Vaccines Market : Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2027

Global Neglected Tropical Diseases Drugs and Vaccines Market: Overview

Pertinent issues like sanitation, cleanliness, and hygiene still worry several parts of the world even today. This results in spike of infections and diseases that more often than not, get neglected. They are termed as neglected tropical diseases. World Health Organization claims that these disease affect nearly 1 billion people across the globe. This explains the potential for companies in the global neglected tropical diseases drugs and vaccines market. Over the years, the market for drugs and vaccines for neglected tropical diseases has garnered weight which can be attributed to the rising measures taken by WHO and members of the United Nations to reduce disease burden.


An upcoming report on the global neglected tropical diseases drugs and vaccines market by Transparency Market Research promises to provide every minute detail pertinent for scaling business in the coming years. It covers the existing trends, challenges, opportunities, key developments, geographical analysis, and competitive landscape.

Global Neglected Tropical Diseases Drugs and Vaccines Market: Notable Developments

Inundated with infections and diseases, the number of notable developments in the global neglected tropical diseases drugs and vaccines market is exhaustive. Some the prominent developments that could aid growth in the coming years include
  • Takeda’s vaccine for dengue, Dengvaxia, is expected to hit the market by 2020. This will instill competition among players. Further, vaccine for Zika virus in\s under clinical trial phase II or III.
  • In 2017, the World Health Organization (WHO) decided to add new diseases like deep mycoses, snakebites, chromoblastomycosis, and other ectoparasites. The development came after WHO received proposals from different stakeholders to include them in the list of neglected tropical diseases.
  • During Global Partners Meeting in April 2017, many players of the global NTD drugs and vaccines market along with philanthropists, and governments decided to pump in US$800 million in the next 5 to 7 years to eliminate NTDs.
  • At least nine leading pharmaceutical companies, the WHO, technprenuer and philanthropist Bill Gates, and several political leaders across the world came together to sign the London Declaration. The agreement vows to raise funds to eradicate at least 10 out of the 17 targeted NTDs.

Besides these collective efforts, most players in the global market for NTD drugs and vaccines are investing in research and development to launch new drugs for the targeted diseases. Some of the leading brands in the global neglected tropical diseases drugs and vaccines market are GSK, Merck, and Takeda.

Global Neglected Tropical Diseases Drugs and Vaccines Market: Key Trends

Increasing Public Private Partnerships

The past decade when it comes to NTDs has been about collective efforts from all the stakeholders of healthcare to eliminate NTDs. Several new programs have been launched to roll out measures that will increase awareness, provide treatment, and reduce disease burden especially in under developed countries. As more such programs come into effect, the demand for vaccines and drugs for NTDs will shoot up.

Growing Migrant Population in Developed Nations

According to the International Migration Report of 2017, out of the 85 million total migrants since 2000, 64 million are into developed or developing countries. This trend has impacted the disease burden due to NTDs over the years. As a result, most developed countries have enforced laws to protect natives from NTDs. This has augmented demand in the last 10 years for drugs and vaccines to treat or prevent neglected tropical diseases.


Need for Quality Drugs

High quality drugs has remained a long-unsolved issue in the global neglected tropical diseases drugs and vaccines market. The last decade has been witness to huge amounts of funding to develop better drugs to treat NTDs. About 70 drugs have entered clinical phase trial I, and some of them are in the final stages of development. It is highly expected that in the forecast period, one could witness launch of one or more drugs.

Global Neglected Tropical Diseases Drugs and Vaccines Market: Geographical Analysis


In the widespread market for NTD drugs and vaccines, North America is expected to remain at the helm. The heavy inflow of migrant population from underdeveloped or developing nations is the prime reason influencing demand here. Besides, Europe will also remain equally important for players in the global neglected tropical diseases drugs and vaccines market. On the other hand, it is predicted that Asia Pacific will emerge as a target region. Developing healthcare, thrust from governments to reduce NTDs, and increasing awareness among people, will stimulate demand here.

Next-Generation IV Infusion Pumps Market : Insights and Emerging Trends by 2027

Global Next-Generation IV Infusion Pumps Market: Overview

The global market for next-generation IV infusion pumps has been expanding on account of advancements in the field of intravenous treatments. Several liquids need to be administered in patients suffering from chronic diseases, and it is important to carry out the infusion with immense care and precision. Henceforth, the demand within the global next-generation IV infusion pumps market has been rising at a starry rate over the past decade. These pumps are especially manufactured to cater to multiple needs of intravenous treatments. The intravenous route of administration is commonly used for patients who suffer from swallowing problems such as dysphagia. Hence, the relevance of next-generation IV infusion pumps has given an impetus to the growth of the global market in recent times. Furthermore, the use of syringes has been replaced with infusion pumps, and this factor has in turn given an impetus to the growth of the global next-generation IV infusion pumps marker. Owing to the factors mentioned above, the global next-generation IV infusion pumps market is projected to reach new heights in the years to follow.


The global next-generation IV infusion pumps market has been segmented on the basis of the following parameters: Latin America, North America, the Middle East and Africa, Europe, an Asia Pacific. The aforementioned segments play a pivotal part in enunciating the growth dynamics of the global next-generation IV infusion pumps market.

A report added by Transparency Market Research (TMR) on the global next-generation IV infusion pumps market is an explanation of multiple dynamics of market growth. The report runs through several inbound and outbound forces operating in the global next-generation IV infusion pumps market. Furthermore, the regional markets for next-generation IV infusion pumps have also been enunciated in the report. A list of the leading vendors within the global next-generation IV infusion pumps market is also included therein.


Global Next-Generation IV Infusion Pumps Market: Trends and Opportunities

The global market for next-generation IV infusion pumps has been expanding alongside advancements in the field of infusion treatments. The need for intravenous therapy is felt across a wide range of domains within healthcare, and this factor is projected to bring in voluminous revenues into the global market. Increased medical spending by the masses as well as the healthcare fraternity has given an impetus to market growth. Henceforth, the global next-generation IV infusion pumps market is projected to accumulate voluminous revenues in the years to follow.

Global Next-Generation IV Infusion Pumps Market: Market Potential

The profitable prospects of growth within the global next-generation IV infusion pumps market have invited multiple vendors into the market. This trend is expected to result in the launch of improved IV infusion pumps over the forthcoming years. Moreover, the investments made by global stakeholders in the global next-generation IV infusion pumps market shall also accelerate the rate of market growth.


Global Next-Generation IV Infusion Pumps Market: Regional Outlook

On the basis of geography, the global next-generation IV infusion pumps can be segmented into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. The market for next-generation IV infusion pumps in Asia Pacific is expanding alongside advancements in the field of intravenous treatment.

Global Next-Generation IV Infusion Pumps Market: Competitive Landscape


Some of the key vendors in the global next-generation IV infusion pumps market are Becton, Dickinson Company, B. Braun Melsungen AG, and Terumo Corporation.

Nanoparticle Analysis Market Boosting the Healthcare Industry Worldwide

Nanoparticle Analysis Market: Overview

The National Center for Biotechnology Information (NCBI) defines nanotechnology as the involvement of science and engineering for the design, synthesis, characterization, and also application of materials whose functional organization, in at least one dimension, lies on the nanometer scale. At these scales, it becomes important to consider individual molecules and interacting molecular groups in relation to the bulk macroscopic properties of the material, the fundamental molecular structure, which eventually allows control over the macroscopic physical and chemical properties. Nanoparticles are extremely small objects having dimensions, which are measured in nanometers (nm). Nanoparticles generally have at least one dimension less than 100nm in size. Nanoparticles are gaining the focus of materials scientists and engineers because these comprise properties different to those observed in bulk samples of the same material. Nanoparticles smaller than 10nm are observed to emit light or glow, with light frequency that is determined by the composition of the material and particle size. These nanoparticles are called quantum dots. Nanoparticle analysis uses light scattering technique for the detection of particle size distribution, molecular weight, zeta potential, etc. of samples. It can be used for the analysis of samples of nanoparticle, emulsion, submicron suspension, colloform, etc. Nanoparticle analysis is primarily used to measure particle size, protein aggregation, particle concentration, and Zeta potential.


Nanoparticle Analysis Market: Key Trends

Growing focus on nanotechnology research and development, technological advancements in the analysis of nanoparticles, and rise in government investments for the development of health care sector are the key factors driving the global nanoparticle analysis market. Moreover, increase in demand for customized medical implants and need for less sample volume and sample preparation in advanced analytical techniques are the other factors propelling the global market. However, high cost of nanoparticle analysis instruments and technologies is projected to hamper the growth of the global nanoparticle analysis market

Nanoparticle Analysis Market: Segmentation

In terms of technology, the global nanoparticle analysis market can be segmented into microscopy, dynamic light scattering (DLS) measurement, laser diffraction, nanoparticle tracking analysis (NTA), resonant mass measurement, X-ray diffraction (XRD), and others. The others segment includes differential mobility analyzer (DMA), nanoparticle surface area monitor (NSAM), condensation particle counter (CPC), and scanning mobility particle sizer (SMPS). The microscopy segment can be classified into scanning electron microscopy (SEM), transmission electron microscopy (TEM), and atomic force microscopy (AFM). Based on application, the market can be divided into chemical, printing & coating, and pharmaceuticals. In terms of end-user, the global nanoparticle analysis market can be categorized into pharmaceutical & medical device companies and research & development institutions.


Nanoparticle Analysis Market: Regional Analysis

Based on region, the global nanoparticle surface analysis market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period, attributed to the presence of large number of pharmaceutical and biopharmaceutical companies, rise in research and development on nanotechnology, increase in adoption of technological advancements. The market in Asia Pacific is expected to witness rapid growth due to numerous opportunities for key players in the region, rise in government initiatives to improve the health care sector, and increase in research and developmental activities.

Nanoparticle Analysis Market: Competitive Landscape

Key players in the global nanoparticle analysis market include Malvern Panalytical Ltd., Shimadzu Corporation, HORIBA, Ltd., Beckman Coulter, Inc., Agilent Technologies, Inc., Wyatt Technology Corporation, Bruker, Hitachi, Ltd., JEOL Ltd., and TSI. These players have adopted strategies such as collaborations, partnerships, agreements, and new product development to gain competitive advantage in the global nanoparticle analysis market.



The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Endoscope Camera Heads Market Research by Key players, Type and Application, Future Growth to 2027

Endoscope Camera Heads Market: Overview

Endoscope camera head is a visualization system used for medical diagnosis. It helps in viewing the internal body parts. Endoscope camera head provides HD image of the body which is transferred to the screen for viewing the image. Endoscopy procedures are performed by inserting a rod shaped telescope called endoscope and specialized instruments through small incisions in the body. These procedures can be diagnostic as well as operative in nature, and are used in a number of medical surgeries. Endoscopy procedures are minimally invasive, and hence have obvious advantages over open surgeries. Lesser scars, quick recovery, shorter hospital stay, reduced blood loss, and minimal chances of infection are the key factors driving demand for endoscopy surgeries.


Endoscope Camera Heads Market: Key Trends

The global endoscope camera heads market is driven by rise in prevalence of intestinal disorders and increase in the geriatric population. Moreover, surge in technological innovations and investment by public and private sectors for the advancement of health care are projected to boost the market during the forecast period. For instance, multinational companies such as Panasonic, Cannon, and Sony have made significant investments in the endoscopy market in the past few years. These conglomerates have invested in companies that already have presence in the endoscopy market. In 2014, Covidien completed the acquisition of Given Imaging Ltd., a leader in capsule endoscopy with its flagship product PillCam. Additionally, increase in the number of surgeries such as urological, cardiovascular, neurological, and arthroscopy is expected to drive the market during the forecast period. Endoscopes are used in the diagnosis and treatment of diseases related to urinary tract such as incontinence, frequent urinary tract infection, kidney stone, ureteropelvic junction obstruction, urethral strictures, tumors, and cancerous growth in the urological system. In 2012, the National Cancer Institute estimated total number of 74,690 new cases and 15,580 deaths related to bladder cancer which is the major condition in urological cancer. However, high cost of these devices and shortage of trained surgeons are expected to restrain the global endoscope camera heads market in the next few years. Government funding in emerging countries is likely to create lucrative opportunities in the market during the forecast period.


Endoscope Camera Heads Market: Segmentation

The global endoscope camera heads market can be segmented based on product type, technology, end-user, and region. In terms of product type, the market can be classified into 3D endoscope camera heads, HD endoscope camera heads, and digital endoscope camera heads. Based on technology, the market can be bifurcated into CMOS sensors and CCD sensors. CCD sensors can be categorized into single-chip sensors and three-chip sensors. In terms of end-user, the global endoscope camera heads market can be divided into hospitals, diagnostic centers, ambulatory surgical centers, and others.

Endoscope Camera Heads Market: Regional Analysis

In terms of region, the global endoscope camera heads market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018 owing to the presence of a well-developed health care system. Europe constituted a large share of the global market in 2018. Asia Pacific accounted for significant share of the global market in 2018 due to technological advancements in health care, rise in population, increase in the geriatric population, and surge in the number of endoscopic procedures performed every year, especially in China and India.


Endoscope Camera Heads Market: Competitive Landscape

Key players operating in the global endoscope camera heads market include Olympus Corporation, XION GmbH, B. Braun Melsungen AG, Stryker Corporation, WISAP Medical Technology GmbH, Richard Wolf GmbH, Maxer Endoscopy, Optomic, Inventis, and Happersberger Otopront GmbH.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Monday, June 24, 2019

Clinical Alarm Management Market Analysis 2027, Major Key Players Reviews

Clinical Alarm Management Market: Overview

Clinical alarms are used to warn caregivers of potential adverse or immediate patient conditions. The Association of Advancement of Medical Instrumentation, a non-profitable organization, focuses on the use and development of effective and safe medical equipment. It recognizes alarm management to be a key concern among health care organizations. The rise in technological advancements in the hospital sector and initiations in other medical firms have created awareness over the period of past 25 years. These advancements led to complicated, improved, and sophisticated health monitoring equipment. These advanced health monitoring equipment are manufactured with in-built audible alarms. These alarms are intentionally integrated to alert technicians, operators, or clinicians of any deviation from a preprogrammed or predetermined “normal” status. It is considered to be a pointer tool in improving the safety of patients. This information is further communicated by the operator or clinician to the patient or the concern person.


In the past, only a few medical devices in hospitals had alarm facility. The scenario has reversed since then. Most of the medical devices are manufactured with an alarm function. In acute care units, alarms are generated by a number of devices including respiratory monitoring equipment, infusion pumps, bed or chair alarms, feeding pumps, wound vacuum devices, cardiac monitors, ventilators, patient call systems, and sequential compression devices. There is a set standards for alarm sounds by manufacturers of a particular device. It is the responsibility of the caregivers to distinguish the audible alarms and to react based on the situation, according to the importance of the alarm sound. An alarm is an immediate warning aimed at making caregivers attentive toward the differing parameters of the device. Alarms of devices are predetermined, with many levels or categories or options which may or may not follow a hierarchical order. The hierarchical order of a physiologic monitor is detection of life-threatening situation (crisis alarm), detection of life threatening device malfunction (system failure), detection of imminent danger (warning alarm), detection of potential device malfunction (system warning), and detection of unsafe situation (advisory alarm). The severity of a particular alarm is determined by the kind of sound emitted. For example, an advisory alarm is distinctly different from a crisis alarm. Clinicians or technicians recognize and use the sound of an alarm to determine how fast or what to respond. Alarms in therapeutic devices do not have a hierarchical order, hence the alarm sounds the same pattern continuously, regardless of the situation


Clinical Alarm Management Market: Key Trends

Increase in the geriatric population, awareness about patient safety, rise in prevalence of chronic diseases, and surge in alarm fatigue are the major drivers of the global clinical alarm management market. However, adverse events and complications associated with devices and lack of product standardization are the factors anticipated to hamper market growth during the forecast period.

Clinical Alarm Management Market: Segmentation

The global clinical alarm management market can be segmented based on component, product, end-user, and region. In terms of component, the global market can be bifurcated into solutions and services. The services segment can be classified into implementation & integration and consulting. The solutions segment is projected to account for major market share during the forecast period. Based on product, the global clinical alarm management market can be categorized into nurse call systems, physiological monitors, bed alarms, EMR integration systems, ventilators, and others (pulse oximeters and infusion pumps). Usage of EMR integration systems is anticipated to rise during the forecast period due to technological developments. In terms of end-user, the global market can be divided into hospitals, long-term care centers, ambulatory care centers & home care settings, and others. The ambulatory care centers & home care settings segment is expected to capture significant market share during the forecast period.


Clinical Alarm Management Market: Regional Analysis

In terms of region, the global clinical alarm management market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. North America is likely to be a major market during the forecast period. The region’s dominance is attributed to strategic presence of key players in the U.S. and Canada.

Clinical Alarm Management Market: Competitive Landscape


Key players operating in the global clinical alarm management market are Medtronic, General Electric Company, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Baxter, Vocera Communications, Extension, LLC, Koninklijke Philips N.V., Ascom, Spok, Inc., and Bernoulli, among others.

Medical Device CROs Market Highly Favorable to the Growth Rate by 2019 to 2027

Global Medical Device CROs Market: Overview 

The World Bank said, more than 50,000 different types of medical devices are been used across the everyday in health care facilities worldwide. Growing adoption of these kind of services across the healthcare is driving growth of the global medical device CROs market.


This report on medical device CROs market begins with a thorough executive summary market overview section. These two sections offer vital understanding on diverse macro and microeconomic factors, which influences the growth of medical device CROs market.

Global Medical Device CROs Market: Notable Development 

Numerous companies are entering in to the market with some technological advancement, which is increasing competition and driving growth of the market. For instance, Belgium-based Materialise is utilizing years of experience on the 3D printing to wide its variety of industries including healthcare, aerospace, automotive, art and design. These initiatives by companies are driving growth of the global medical device CROs market.


Global Medical Device CROs Market: Drivers and Restraints 

In the anticipated future, the developing multifaceted nature of clinical preliminaries and interest for solid proof on restorative advantages offered by different medical devices are probably going to provoke more engineer organizations to re-appropriate different parts of their tasks. The developing practices have driven various new players to enter the agreement administrations area. Besides, to adapt up to rising advances and the most recent research slants, a few inheritance CROs are additionally reexamining their operational models and business techniques. Additionally, the interest for coordinated information stages to oversee and examine a tremendous measure of information, combined with difficulties related with unstructured datasets and information security, has brought about a few cooperation and procurement understandings among CROs and information the board arrangements suppliers.

However, the execution of exceedingly stringent administrative rules, explicitly for devices presenting medium to high hazard to purchasers, render them subject to thorough quality evaluations. The previously mentioned difficulties have driven a few players in the business to re-appropriate a noteworthy piece of their clinical stage look into endeavors to able contract explore associations (CROs). A moderately bigger extent of device engineers come up short on the required inside assets and specialized mastery to direct in-house clinical preliminaries. In addition, the expenses related with procuring the fundamental foundation/capacities for such expound look into activities are high; in this way, it is hard for organizations with restricted accounts to start and oversee clinical examinations without anyone else.


Global Medical Device CROs Market: Geographical Analysis 

Based on the region, the medical device CROs market is segmented in to five parts such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Of these, North America is expected to dominate the global medical device CROs market owing to robust development in the region. Additionally, thanks to early adoption of the advamced technologies, the region is expected to remain dominant in the region.

Global Medical Device CROs Market: Companies Mentioned


Some of the players operating in the global medical device CROs market are Charles River Laboratories, Eurofins Scientific, Chiltern, CMIC Group, FMD K&L, Medpace, ICON, NAMSA, Novella Clinical, Pharmaceutical Product Development (PPD), PAREXEL International, Promedica International, WuXi AppTec, and Syneos Health.

Nanopharmaceuticals Market by Technology Advancement and Future Outlook 2019 - 2027

Global Nanopharmaceuticals Market: An Overview

The global nanopharmaceuticals is expected to garner a stellar growth in the forecast period. This is mainly due to increasing prevalence of chronic diseases such as cancer, infectious diseases, cardiovascular diseases and other diseases.

Nanopharmaceuticals can be elaborated as Nanotechnology-based pharmaceuticals. They are known for offering potential solutions to fundamental problems of patients in the drug industry. With further research and development activities, the cost of nanopharmaceuticals drugs is expected to reduce. However, there are a few hurdles which need to be overcome before nanopharmaceuticals become an integral part of modern medicine.


Nanopharmaceuticals are particles of 10 to 1,000 nanometers that are used for drug manufacturing. Owing to their diverse shape and composition, they are have several benefits over their counterparts.

Global Nanopharmaceuticals Market: Notable Developments

The researchers in the nanopharmaceuticals market are working on a drug called Camptothecin. This nanopharmaceuticals has ability to inhibit of topoisomerase which is used for treatment of cancer. The drug was unsuccessful due to poor drug solubility. In order to address this issue, scientists are working on polymeric nanoparticle comprised of cyclodextrin-poly(ethylene glycol) copolymer (CDP) conjugated to CPT (CRLX101. This is expected to offer further opportunities in the nanapharmaceuticals market.


Global Nanopharmaceuticals Market: Key Trends

The global nanopharmaceuticals market is expected to rise at a significant pace during the forecast period. This is mainly due the increasing research and development activities for discovery of new products.

Major players in the nanopharmaceuticals market are ramping there investments inorder to offer new and improved products. This is expected to address critical and unmet needs of patients. This can be attributes by the fact that in August 2017, Jazz Pharmaceuticals, a key player in the market 3received FDA approval for Vyxeos, used for the treatment of acute myeloid leukemia.

On the flipside factors like need to improve functioning, toxicity issues and less solubility of nenopharmaceuticals are anticipated to hinder the nanapharmaceuticals market growth in the coming period.

Nevertheless, growth is nanopharmaceuticals market is fuel by increasing incidences of cardiovascular diseases, cancer, infectious diseases, and advantages of nanopharmaceuticals other conventional medicines.

Request for TOC @  https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=66464

Global Nanopharmaceuticals Market: Regional Outlook

The global nanopharmaceuticals market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The global nanopharmaceticals market in North America is likely to grow at a significant pace during the forecast period. This is mainly due to the significant rise in research and development activities in the region and early adoption of advanced therapeutics. Apart from this, presence of key players is another factor behind the fast track growth of the nanopharmaceuticals market. The revenue generated by these players in the region is expected to boost the nanopharmaceuticals market.

Global Nanopharmaceuticals Market: Competitive Market

The competition in the nanopharmaceuticals market is fierce and intense owing to the presence of large number of players in the nanopharmaceuticals market. These players are adopting several strategies to stay ahead of each other. Some of them are mergers and acquisitions, business expansion, collaboration. Some of the key players operating in the global nanopharmaceuticals are JOHNSON & JOHNSON, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Sanofi S.A, Hoffmann-La Roche AG, Shire Plc., and Teva Pharmaceuticals Industries Limited.


The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.